HealThink at ISPOR Europe 2025
We are excited to announce the participation of HealThink in ISPOR Europe 2025 (November 9-12, Glasgow)! During the conference, we will have the opportunity to present three of our studies:
1. A Generalizable Discrete Event Simulation Framework to Assess Clinical and Economic Impact of Prescription Protocol Revisions (MSR3)– Monday, 10 November | Poster Session 1 | Cardiovascular Disorders (Poster here: https://www.ispor.org/heor-resources/presentations-database/presentation-cti/ispor-europe-2025/poster-session-1-2/a-generalizable-discrete-event-simulation-framework-to-assess-clinical-and-economic-impact-of-prescription-protocol-revisions )
Author(s): Panos Stafylas, MD, MSc, PhD (1), Christiana Tychala, BSc, MSc (1), Andreas Georgiou, BSc, PhD (2)2, Konstantinos Kaparis, BSc, PhD (2), Demosthenes Panagiotakos, BSc, PhD (3), ZOI STEFANIDOU, BA, MSc (4), Christos Stafylas, BSc (5), KELLY AVGITIDOU, BSc, PhD (1), Vassilis Homer Aletras, BSc, MSc, PhD (2).
1 HealThink, Thessaloniki, Greece, 2 Department of Business Administration, University of Macedonia, Thessaloniki, Greece, 3 Department of Nutrition and Dietetics, School of Health Sciences and Education, Harokopio University, Athens, Greece, 4 ELPEN Pharmaceutical SA, Athens, Greece, 5 School of Informatics, Aristotle University of Thessaloniki, Thessaloniki, Greece.
2. Early Health Technology Assessment and Cost-Effectiveness of the National Cardiovascular Disease Prevention Program in Greece (HTA118)– Monday, 10 November, Poster Session 2 | Cardiovascular Disorders (Poster here: https://www.ispor.org/heor-resources/presentations-database/presentation-cti/ispor-europe-2025/poster-session-2-2/early-health-technology-assessment-and-cost-effectiveness-of-the-national-cardiovascular-disease-prevention-program-in-greece )
Author(s): Panos Stafylas, MD, MSc, PhD (1), Charalambos Vlachopoulos, MD, PhD (2), Evangelos Liberopoulos, MD, PhD (3), Dimitri Richter, MD, PhD (4), Christos Stafylas, BSc (5), Alexandros Ginis, BSc, PhD (6), Christiana Tychala, BSc, MSc (1), Panagiotis Katrapas, MD, PhD (6), Konstantinos Kaparis, BSc, PhD (7), Andreas Georgiou, BSc, PhD (7), Vassilis Homer Aletras, BSc, PhD (7), Demosthenes Panagiotakos, MD, PhD (8).
1 HealThink, Thessaloniki, Greece, 2 First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodis, Athens, Greece, 3 1st Department of Propaedeutic and Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, 4 Cardiology Department, Euroclinic Hospital, Athens, Greece, 5 School of Informatics, Aristotle University of Thessaloniki, Thessaloniki, Greece, 6 ELPEN Pharmaceutical SA, Athens, Greece, 7 Department of Business Administration, University of Macedonia, Thessaloniki, Greece, 8 Department of Nutrition and Dietetics, School of Health Sciences and Education, Harokopio University, Athens, Greece.
3. Population-Level Impact Assessment of the Revised Dyslipidaemia Prescription Protocol in Greece Using Simulation Modeling (HSD89)– Tuesday, 11 November | Poster Session 4 | Cardiovascular Disorders (Poster here: https://www.ispor.org/heor-resources/presentations-database/presentation-cti/ispor-europe-2025/poster-session-4-2/population-level-impact-assessment-of-the-revised-dyslipidemia-prescription-protocol-in-greece-using-simulation-modeling )
Author(s): Panos Stafylas, MD, MSc, PhD (1), Christiana Tychala, BSc, MSc (1), Demosthenes Panagiotakos, BSc, PhD (2), Dimitri Richter, MD, PhD (3), Alexandros Ginis, MD, PhD (4), Christos Stafylas, BSc (5), Konstantinos Papadopoulos, BSc (4), Marilena Lolaka, BSc (4), Angeliki Avgitidou, BSc, PhD (1), Konstantinos Kaparis, BSc, PhD (6), Vassilis Homer Aletras, BSc, PhD (6), Andreas Georgiou, BSc, PhD (6), Evangelos Liberopoulos, MD, PhD (7), Charalambos Vlachopoulos, MD, PhD (8).
1 HealThink, Thessaloniki, Greece, 2 Department of Nutrition and Dietetics, School of Health Sciences and Education, Harokopio University, Athens, Greece, 3 Cardiology Department, Euroclinic Hospital, Athens, Greece, 4 ELPEN Pharmaceutical SA, Athens, Greece, 5 School of Informatics, Aristotle University of Thessaloniki, Thessaloniki, Greece, 6 Department of Business Administration, University of Macedonia, Thessaloniki, Greece, 7 1st Department of Propaedeutic and Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, 8 First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodis, Athens, Greece.
We would like to express our sincere thanks to all the authors for their dedication and collaboration — your contributions were invaluable!
We look forward to connecting with colleagues, researchers, and professionals in HEOR and health access, and to sharing our insights and innovations focused on improving patient outcomes. Come visit us at the conference or reach out to arrange a meeting — we’d love to see you there!
More info about the conference here.
1. A Generalizable Discrete Event Simulation Framework to Assess Clinical and Economic Impact of Prescription Protocol Revisions (MSR3)– Monday, 10 November | Poster Session 1 | Cardiovascular Disorders (Poster here: https://www.ispor.org/heor-resources/presentations-database/presentation-cti/ispor-europe-2025/poster-session-1-2/a-generalizable-discrete-event-simulation-framework-to-assess-clinical-and-economic-impact-of-prescription-protocol-revisions )
Author(s): Panos Stafylas, MD, MSc, PhD (1), Christiana Tychala, BSc, MSc (1), Andreas Georgiou, BSc, PhD (2)2, Konstantinos Kaparis, BSc, PhD (2), Demosthenes Panagiotakos, BSc, PhD (3), ZOI STEFANIDOU, BA, MSc (4), Christos Stafylas, BSc (5), KELLY AVGITIDOU, BSc, PhD (1), Vassilis Homer Aletras, BSc, MSc, PhD (2).
1 HealThink, Thessaloniki, Greece, 2 Department of Business Administration, University of Macedonia, Thessaloniki, Greece, 3 Department of Nutrition and Dietetics, School of Health Sciences and Education, Harokopio University, Athens, Greece, 4 ELPEN Pharmaceutical SA, Athens, Greece, 5 School of Informatics, Aristotle University of Thessaloniki, Thessaloniki, Greece.
2. Early Health Technology Assessment and Cost-Effectiveness of the National Cardiovascular Disease Prevention Program in Greece (HTA118)– Monday, 10 November, Poster Session 2 | Cardiovascular Disorders (Poster here: https://www.ispor.org/heor-resources/presentations-database/presentation-cti/ispor-europe-2025/poster-session-2-2/early-health-technology-assessment-and-cost-effectiveness-of-the-national-cardiovascular-disease-prevention-program-in-greece )
Author(s): Panos Stafylas, MD, MSc, PhD (1), Charalambos Vlachopoulos, MD, PhD (2), Evangelos Liberopoulos, MD, PhD (3), Dimitri Richter, MD, PhD (4), Christos Stafylas, BSc (5), Alexandros Ginis, BSc, PhD (6), Christiana Tychala, BSc, MSc (1), Panagiotis Katrapas, MD, PhD (6), Konstantinos Kaparis, BSc, PhD (7), Andreas Georgiou, BSc, PhD (7), Vassilis Homer Aletras, BSc, PhD (7), Demosthenes Panagiotakos, MD, PhD (8).
1 HealThink, Thessaloniki, Greece, 2 First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodis, Athens, Greece, 3 1st Department of Propaedeutic and Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, 4 Cardiology Department, Euroclinic Hospital, Athens, Greece, 5 School of Informatics, Aristotle University of Thessaloniki, Thessaloniki, Greece, 6 ELPEN Pharmaceutical SA, Athens, Greece, 7 Department of Business Administration, University of Macedonia, Thessaloniki, Greece, 8 Department of Nutrition and Dietetics, School of Health Sciences and Education, Harokopio University, Athens, Greece.
3. Population-Level Impact Assessment of the Revised Dyslipidaemia Prescription Protocol in Greece Using Simulation Modeling (HSD89)– Tuesday, 11 November | Poster Session 4 | Cardiovascular Disorders (Poster here: https://www.ispor.org/heor-resources/presentations-database/presentation-cti/ispor-europe-2025/poster-session-4-2/population-level-impact-assessment-of-the-revised-dyslipidemia-prescription-protocol-in-greece-using-simulation-modeling )
Author(s): Panos Stafylas, MD, MSc, PhD (1), Christiana Tychala, BSc, MSc (1), Demosthenes Panagiotakos, BSc, PhD (2), Dimitri Richter, MD, PhD (3), Alexandros Ginis, MD, PhD (4), Christos Stafylas, BSc (5), Konstantinos Papadopoulos, BSc (4), Marilena Lolaka, BSc (4), Angeliki Avgitidou, BSc, PhD (1), Konstantinos Kaparis, BSc, PhD (6), Vassilis Homer Aletras, BSc, PhD (6), Andreas Georgiou, BSc, PhD (6), Evangelos Liberopoulos, MD, PhD (7), Charalambos Vlachopoulos, MD, PhD (8).
1 HealThink, Thessaloniki, Greece, 2 Department of Nutrition and Dietetics, School of Health Sciences and Education, Harokopio University, Athens, Greece, 3 Cardiology Department, Euroclinic Hospital, Athens, Greece, 4 ELPEN Pharmaceutical SA, Athens, Greece, 5 School of Informatics, Aristotle University of Thessaloniki, Thessaloniki, Greece, 6 Department of Business Administration, University of Macedonia, Thessaloniki, Greece, 7 1st Department of Propaedeutic and Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, 8 First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodis, Athens, Greece.
We would like to express our sincere thanks to all the authors for their dedication and collaboration — your contributions were invaluable!
We look forward to connecting with colleagues, researchers, and professionals in HEOR and health access, and to sharing our insights and innovations focused on improving patient outcomes. Come visit us at the conference or reach out to arrange a meeting — we’d love to see you there!
More info about the conference here.